PROKIDNEY CORP. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
PROK on Nasdaq
Location
Winston Salem, NC
Fiscal year end
31 December
Latest financial report
18 Mar 2026

Quick Takeaways

  • PROK - PROKIDNEY CORP. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity 6.9%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+18%</span>.
  • Most recent SEC facts end date: 31 Dec 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-12-31) highlights Return On Equity 6.9%, Return On Assets -17.8%, and Current Ratio 9.13x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

4.6/100

Weak Confidence medium

Return On Equity

6.9%

Metric score 0.0/100

Return On Assets

-18%

Metric score 0.0/100

Financial Health

Current Ratio
9.13x
Debt to Equity
-0.03x

Strengths

No strong signals yet.

Watchpoints

Return On Equity, Return On Assets, and Current Ratio

Key metrics snapshot

Return On Equity

6.9%

YoY: +18%

Industry median: -47% (n=218)

View history

Return On Assets

-18%

YoY: +25%

Industry median: -44% (n=217)

View history

Current Ratio

9.13x

YoY: -16%

Industry median: 3.67x (n=218)

View history

Debt-to-equity

-0.03x

YoY: +13%

Industry median: 0.31x (n=169)

View history

NetIncomeLoss YoY

-13%

YoY:

Industry median: -12% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity 6.9% +18%
Return On Assets -18% +25%

Financial Health

Metric Latest value YoY change
Current Ratio 9.13x -16%
Debt-to-equity -0.03x +13%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -13%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $114,123,000 -11%
General and Administrative Expense $51,777,000 -7.7%
Operating Income (Loss) $165,007,000 +10%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $151,198,000 +7.8%
Income Tax Expense (Benefit) $414,000 -193%
Cash and Cash Equivalents, at Carrying Value $108,537,000 +9.5%
Other Assets, Current $2,804,000 +3405%
Assets, Current $280,679,000 -29%
Property, Plant and Equipment, Net $51,231,000 +21%
Operating Lease, Right-of-Use Asset $3,590,000 +25%
Assets $335,574,000 -24%
Accounts Payable, Current $940,000 -74%
Accrued Liabilities, Current $28,731,000 -7.7%
Liabilities, Current $30,742,000 -15%
Accrued Income Taxes, Noncurrent $1,074,000 +44%
Operating Lease, Liability, Noncurrent $2,905,000 +21%
Liabilities $34,781,000 -12%
Accumulated Other Comprehensive Income (Loss), Net of Tax $56,000 -57%
Retained Earnings (Accumulated Deficit) $1,269,835,000 -5.7%
Stockholders' Equity Attributable to Parent $1,011,197,000 -1.6%
Liabilities and Equity $335,574,000 -24%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $108,537,000 +9.5%
Deferred Tax Assets, Valuation Allowance $17,527,000 +153%
Deferred Tax Assets, Gross $17,527,000 +119%
Operating Lease, Liability $3,959,000 +26%
Depreciation $5,722,000 +32%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $69,060,000 -13%
Lessee, Operating Lease, Liability, to be Paid $4,924,000 +29%
Operating Lease, Liability, Current $1,054,000 +42%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,292,000 +13%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,429,000 +41%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 +3.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $965,000 +41%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,075,000 +7.3%
Deferred Tax Assets, Operating Loss Carryforwards $8,941,000 +6152%
Unrecognized Tax Benefits $1,075,000 +44%
Lessee, Operating Lease, Liability, to be Paid, Year Four $457,000 -25%
Additional Paid in Capital $258,552,000 +26%
Deferred Tax Assets, Net of Valuation Allowance $0 -100%
Share-based Payment Arrangement, Expense $25,336,000 -14%
Interest Expense $4,000 -56%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY